PubMed:7510691
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-133 | Sentence | denotes | The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. |
| T2 | 134-225 | Sentence | denotes | FK506, an immunosuppressant, inhibits the production of several cytokines in T lymphocytes. |
| T3 | 226-456 | Sentence | denotes | We observed that FK506 suppressed the transcription of a chemotactic cytokine, interleukin-8 (IL-8) in a human T cell line, Jurkat cells, activated by phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin). |
| T4 | 457-609 | Sentence | denotes | By deleted and mutated analysis of the IL-8 promoters, the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin. |
| T5 | 610-783 | Sentence | denotes | FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli. |
| T6 | 784-966 | Sentence | denotes | In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were recognized with anti-JunD or c-Fos antibody. |
| T7 | 967-1192 | Sentence | denotes | In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49). |
| T8 | 1193-1545 | Sentence | denotes | Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors. |
| T9 | 1546-1759 | Sentence | denotes | Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-sensitive pathway involving Ca2+ mobilization. |
| T1 | 0-133 | Sentence | denotes | The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. |
| T2 | 134-225 | Sentence | denotes | FK506, an immunosuppressant, inhibits the production of several cytokines in T lymphocytes. |
| T3 | 226-456 | Sentence | denotes | We observed that FK506 suppressed the transcription of a chemotactic cytokine, interleukin-8 (IL-8) in a human T cell line, Jurkat cells, activated by phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin). |
| T4 | 457-609 | Sentence | denotes | By deleted and mutated analysis of the IL-8 promoters, the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin. |
| T5 | 610-783 | Sentence | denotes | FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli. |
| T6 | 784-966 | Sentence | denotes | In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were recognized with anti-JunD or c-Fos antibody. |
| T7 | 967-1192 | Sentence | denotes | In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49). |
| T8 | 1193-1545 | Sentence | denotes | Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors. |
| T9 | 1546-1759 | Sentence | denotes | Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-sensitive pathway involving Ca2+ mobilization. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 4-45 | DNA | denotes | interleukin-8 AP-1 and kappa B-like sites |
| T2 | 198-207 | protein | denotes | cytokines |
| T3 | 211-224 | cell_type | denotes | T lymphocytes |
| T4 | 283-303 | protein | denotes | chemotactic cytokine |
| T5 | 305-318 | protein | denotes | interleukin-8 |
| T6 | 320-324 | protein | denotes | IL-8 |
| T7 | 331-348 | cell_line | denotes | human T cell line |
| T8 | 350-362 | cell_line | denotes | Jurkat cells |
| T9 | 496-510 | DNA | denotes | IL-8 promoters |
| T10 | 516-543 | DNA | denotes | AP-1 and kappa B-like sites |
| T11 | 658-662 | DNA | denotes | AP-1 |
| T12 | 666-684 | DNA | denotes | kappa B-like sites |
| T13 | 859-868 | DNA | denotes | AP-1 site |
| T14 | 938-947 | protein | denotes | anti-JunD |
| T15 | 951-965 | protein | denotes | c-Fos antibody |
| T16 | 1046-1081 | protein | denotes | kappa B-like site binding complexes |
| T17 | 1116-1126 | protein | denotes | antibodies |
| T18 | 1139-1164 | protein | denotes | human Rel family proteins |
| T19 | 1166-1171 | protein | denotes | c-Rel |
| T20 | 1173-1176 | protein | denotes | p65 |
| T21 | 1178-1181 | protein | denotes | p50 |
| T22 | 1187-1190 | protein | denotes | p49 |
| T23 | 1316-1328 | DNA | denotes | kappa B site |
| T24 | 1332-1356 | DNA | denotes | immunoglobulin (Ig) gene |
| T25 | 1367-1377 | protein | denotes | NF-kappa B |
| T26 | 1436-1458 | DNA | denotes | IL-8 kappa B-like site |
| T27 | 1466-1478 | DNA | denotes | kappa B site |
| T28 | 1529-1544 | protein | denotes | binding factors |
| T29 | 1594-1622 | DNA | denotes | IL-2 NF-AT and NFIL-2A sites |
| T30 | 1630-1642 | DNA | denotes | kappa B site |
| T31 | 1657-1661 | protein | denotes | IL-8 |
| T32 | 1662-1666 | DNA | denotes | AP-1 |
| T33 | 1671-1689 | DNA | denotes | kappa B-like sites |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-45 | NP | denotes | The interleukin-8 AP-1 and kappa B-like sites |
| C2 | 73-96 | NP | denotes | FK506-sensitive pathway |
| C3 | 134-139 | NP | denotes | FK506 |
| C4 | 141-161 | NP | denotes | an immunosuppressant |
| C5 | 243-248 | NP | denotes | FK506 |
| C6 | 281-303 | NP | denotes | a chemotactic cytokine |
| C7 | 305-325 | NP | denotes | interleukin-8 (IL-8) |
| C8 | 329-348 | NP | denotes | a human T cell line |
| C9 | 350-362 | NP | denotes | Jurkat cells |
| C10 | 377-455 | NP | denotes | phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin) |
| C11 | 512-543 | NP | denotes | the AP-1 and kappa B-like sites |
| C12 | 591-608 | NP | denotes | PMA and ionomycin |
| C13 | 610-615 | NP | denotes | FK506 |
| C15 | 654-684 | NP | denotes | the AP-1 or kappa B-like sites |
| C14 | 627-684 | NP | denotes | the transcriptions through the AP-1 or kappa B-like sites |
| C16 | 739-744 | NP | denotes | those |
| C17 | 813-818 | NP | denotes | FK506 |
| C18 | 872-909 | NP | denotes | PMA/ionomycin-induced nuclear factors |
| C19 | 911-916 | NP | denotes | which |
| C20 | 980-985 | NP | denotes | FK506 |
| C21 | 1046-1081 | NP | denotes | kappa B-like site binding complexes |
| C22 | 1083-1088 | NP | denotes | which |
| C23 | 1244-1249 | NP | denotes | FK506 |
| C24 | 1306-1356 | NP | denotes | authentic kappa B site of immunoglobulin (Ig) gene |
| C25 | 1361-1366 | NP | denotes | which |
| C26 | 1408-1413 | NP | denotes | FK506 |
| C27 | 1653-1689 | NP | denotes | the IL-8 AP-1 and kappa B-like sites |
| C28 | 1707-1730 | NP | denotes | FK506-sensitive pathway |
| R1 | C4 | C3 | coref-appos | an immunosuppressant,FK506 |
| R2 | C5 | C3 | coref-ident | FK506,FK506 |
| R3 | C7 | C6 | coref-appos | interleukin-8 (IL-8),a chemotactic cytokine |
| R4 | C9 | C8 | coref-appos | Jurkat cells,a human T cell line |
| R5 | C11 | C1 | coref-ident | the AP-1 and kappa B-like sites,The interleukin-8 AP-1 and kappa B-like sites |
| R6 | C12 | C10 | coref-ident | PMA and ionomycin,phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin) |
| R7 | C13 | C5 | coref-ident | FK506,FK506 |
| R8 | C15 | C11 | coref-ident | the AP-1 or kappa B-like sites,the AP-1 and kappa B-like sites |
| R9 | C16 | C14 | coref-pron | those,the transcriptions through the AP-1 or kappa B-like sites |
| R10 | C17 | C13 | coref-ident | FK506,FK506 |
| R11 | C19 | C18 | coref-relat | which,PMA/ionomycin-induced nuclear factors |
| R12 | C20 | C17 | coref-ident | FK506,FK506 |
| R13 | C22 | C21 | coref-relat | which,kappa B-like site binding complexes |
| R14 | C23 | C20 | coref-ident | FK506,FK506 |
| R15 | C25 | C24 | coref-relat | which,authentic kappa B site of immunoglobulin (Ig) gene |
| R16 | C26 | C23 | coref-ident | FK506,FK506 |
| R17 | C27 | C15 | coref-ident | the IL-8 AP-1 and kappa B-like sites,the AP-1 or kappa B-like sites |
| R18 | C28 | C2 | coref-ident | FK506-sensitive pathway,FK506-sensitive pathway |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-133 | Sentence | denotes | The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization. |
| S2 | 134-225 | Sentence | denotes | FK506, an immunosuppressant, inhibits the production of several cytokines in T lymphocytes. |
| S3 | 226-456 | Sentence | denotes | We observed that FK506 suppressed the transcription of a chemotactic cytokine, interleukin-8 (IL-8) in a human T cell line, Jurkat cells, activated by phorbol 12-myristate 13-acetate (PMA) and calcium (Ca2+) ionophore (ionomycin). |
| S4 | 457-609 | Sentence | denotes | By deleted and mutated analysis of the IL-8 promoters, the AP-1 and kappa B-like sites were identified as the responsive elements for PMA and ionomycin. |
| S5 | 610-783 | Sentence | denotes | FK506 suppressed the transcriptions through the AP-1 or kappa B-like sites induced by PMA plus Ca(2+)-mobilizing agents, but not those induced by Ca(2+)-independent stimuli. |
| S6 | 784-966 | Sentence | denotes | In gel retardation analysis, FK506 had little effect on the binding to the AP-1 site of PMA/ionomycin-induced nuclear factors, which were recognized with anti-JunD or c-Fos antibody. |
| S7 | 967-1192 | Sentence | denotes | In contrast, FK506 or EGTA (Ca2+ chelator) similarly affected the formation of kappa B-like site binding complexes, which were not recognized by any antibodies against the human Rel family proteins (c-Rel, p65, p50, and p49). |
| S8 | 1193-1545 | Sentence | denotes | Furthermore, we confirmed the previous report that FK506 suppressed the PMA/ionomycin-induced activation through authentic kappa B site of immunoglobulin (Ig) gene, to which NF-kappa B binding was also decreased by FK506, indicating that both IL-8 kappa B-like site and Ig kappa B site are FK506-sensitive in spite of the difference of binding factors. |
| S9 | 1546-1759 | Sentence | denotes | Our results indicate that not only the reported IL-2 NF-AT and NFIL-2A sites and Ig kappa B site, but also the IL-8 AP-1 and kappa B-like sites are terminals of FK506-sensitive pathway involving Ca2+ mobilization. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 73-96 | other_name | denotes | FK506-sensitive pathway |
| T2 | 112-119 | atom | denotes | calcium |
| T3 | 134-139 | other_organic_compound | denotes | FK506 |
| T4 | 144-161 | other_name | denotes | immunosuppressant |
| T5 | 198-207 | protein_family_or_group | denotes | cytokines |
| T6 | 211-224 | cell_type | denotes | T lymphocytes |
| T7 | 243-248 | other_organic_compound | denotes | FK506 |
| T8 | 283-303 | protein_family_or_group | denotes | chemotactic cytokine |
| T9 | 305-318 | protein_molecule | denotes | interleukin-8 |
| T10 | 320-324 | protein_molecule | denotes | IL-8 |
| T11 | 331-348 | cell_line | denotes | human T cell line |
| T12 | 350-362 | cell_line | denotes | Jurkat cells |
| T13 | 377-408 | other_organic_compound | denotes | phorbol 12-myristate 13-acetate |
| T14 | 410-413 | other_organic_compound | denotes | PMA |
| T15 | 419-426 | atom | denotes | calcium |
| T16 | 428-432 | atom | denotes | Ca2+ |
| T17 | 445-454 | other_organic_compound | denotes | ionomycin |
| T18 | 496-500 | protein_molecule | denotes | IL-8 |
| T19 | 516-520 | DNA_domain_or_region | denotes | AP-1 |
| T20 | 525-543 | DNA_domain_or_region | denotes | kappa B-like sites |
| T21 | 591-594 | other_organic_compound | denotes | PMA |
| T22 | 599-608 | other_organic_compound | denotes | ionomycin |
| T23 | 610-615 | other_organic_compound | denotes | FK506 |
| T24 | 658-662 | DNA_domain_or_region | denotes | AP-1 |
| T25 | 666-684 | DNA_domain_or_region | denotes | kappa B-like sites |
| T26 | 696-699 | other_organic_compound | denotes | PMA |
| T27 | 813-818 | other_organic_compound | denotes | FK506 |
| T28 | 859-868 | DNA_domain_or_region | denotes | AP-1 site |
| T29 | 872-875 | other_organic_compound | denotes | PMA |
| T30 | 876-885 | other_organic_compound | denotes | ionomycin |
| T31 | 938-947 | protein_family_or_group | denotes | anti-JunD |
| T32 | 951-965 | protein_family_or_group | denotes | c-Fos antibody |
| T33 | 980-985 | other_organic_compound | denotes | FK506 |
| T34 | 989-993 | other_organic_compound | denotes | EGTA |
| T35 | 995-999 | atom | denotes | Ca2+ |
| T36 | 1046-1081 | protein_complex | denotes | kappa B-like site binding complexes |
| T37 | 1116-1126 | protein_family_or_group | denotes | antibodies |
| T38 | 1139-1164 | protein_family_or_group | denotes | human Rel family proteins |
| T39 | 1166-1171 | protein_molecule | denotes | c-Rel |
| T40 | 1173-1176 | protein_molecule | denotes | p65 |
| T41 | 1178-1181 | protein_molecule | denotes | p50 |
| T42 | 1187-1190 | protein_molecule | denotes | p49 |
| T43 | 1244-1249 | other_organic_compound | denotes | FK506 |
| T44 | 1265-1268 | other_organic_compound | denotes | PMA |
| T45 | 1269-1278 | other_organic_compound | denotes | ionomycin |
| T46 | 1316-1328 | DNA_domain_or_region | denotes | kappa B site |
| T47 | 1332-1356 | DNA_domain_or_region | denotes | immunoglobulin (Ig) gene |
| T48 | 1367-1377 | protein_molecule | denotes | NF-kappa B |
| T49 | 1408-1413 | other_organic_compound | denotes | FK506 |
| T50 | 1436-1440 | protein_molecule | denotes | IL-8 |
| T51 | 1466-1478 | DNA_domain_or_region | denotes | kappa B site |
| T52 | 1483-1488 | other_organic_compound | denotes | FK506 |
| T53 | 1529-1544 | protein_family_or_group | denotes | binding factors |
| T54 | 1630-1642 | DNA_domain_or_region | denotes | kappa B site |
| T55 | 1657-1661 | protein_molecule | denotes | IL-8 |
| T56 | 1662-1666 | DNA_domain_or_region | denotes | AP-1 |
| T57 | 1671-1689 | DNA_domain_or_region | denotes | kappa B-like sites |
| T58 | 1707-1712 | other_organic_compound | denotes | FK506 |
| T59 | 1741-1745 | atom | denotes | Ca2+ |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 410-413 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T3 | 591-594 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T5 | 696-699 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T7 | 872-875 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
| T9 | 1265-1268 | Disease | denotes | PMA | http://purl.obolibrary.org/obo/MONDO_0016692|http://purl.obolibrary.org/obo/MONDO_0018687 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 331-336 | OrganismTaxon | denotes | human | 9606 |
| T2 | 1000-1008 | OrganismTaxon | denotes | chelator | 263156 |
| T3 | 1139-1144 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 211-224 | Body_part | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL_0000084 |
| T2 | 337-343 | Body_part | denotes | T cell | http://purl.obolibrary.org/obo/CL_0000084 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 211-224 | Cell | denotes | T lymphocytes | http://purl.obolibrary.org/obo/CL:0000084 |
| T2 | 337-343 | Cell | denotes | T cell | http://purl.obolibrary.org/obo/CL:0000084 |